Table 3 Differences in clinical indicators between the study group and the conventional group [(x̅ ± s), n(%)]

Conventional group

4.15 ± 0.49

133.94 ± 14.83

8.18 ± 2.02

17.71 ± 1.71

8.65 ± 4.02

Study group

4.80 ± 0.69

143.31 ± 16.84

9.72 ± 1.93

19.62 ± 1.03

7.45 ± 4.12

t

-11.419

-6.060

-7.844

-13.015

2.990

P

< 0.001

< 0.001

< 0.001

< 0.001

0.003

group

2hINS(µU/mL)

FCP(ng·ml-1)

2hCP(ng·ml-1)

FBG(mmol/L)

UAER

Conventional group

10.65 ± 4.12

2.29 ± 0.92

6.13 ± 2.12

7.71 ± 1.79

15.00 ± 9.35

Study group

8.35 ± 4.21

1.98 ± 0.72

5.61 ± 2.12

12.62 ± 2.02

14.50 ± 9.32

t

5.599

3.696

-2.481

-26.382

0.542

P

< 0.001

< 0.001

0.013

< 0.001

0.588

group

UAERgroup, n(%)

SBP(mmHg)

Serum creatinine(µmoI/L)

TC(mmol·L-1)

normal

micro

macro

Conventional group

203(76.89)

54(20.45)

7(2.65)

138.30 ± 5.80

58.30 ± 10.80

4.59 ± 1.27

Study group

124(74.25)

34(20.36)

9(5.39)

145.30 ± 5.80

72.10 ± 9.32

4.42 ± 1.20

t/x2

0.390

-12.207

-13.613

1.383

P

0.532

< 0.001

< 0.001

0.167

group

TG(mmol·L-1)

LDL(mmol·L-1)

HDL(mmol·L-1)

ApoA1(g/L)

ApoB(g/L)

β2-MG(mg·L-1)

Conventional group

1.28 ± 0.69

2.16 ± 0.69

1.17 ± 0.32

1.40 ± 0.12

0.99 ± 0.32

2.49 ± 0.42

Study group

1.86 ± 0.86

2.52 ± 0.63

1.03 ± 0.24

1.47 ± 0.22

0.91 ± 0.12

2.95 ± 0.54

t

-7.715

5.455

4.855

-4.265

3.095

-9.897

P

< 0.001

< 0.001

< 0.001

< 0.001

< 0.001

< 0.001